URGN
URGN

Urogen Pharma Ltd

NASDAQ · Biotechnology
$21.35
+0.83 (+4.04%)
Analyst Consensus
Strong Buy
14 analysts
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +112.5% upside
Low Target $37.53
Average Target $45.36
High Target $61.85
Current Price $21.35
Current
$21.35
Target
$45.36
$37.53 $45.36 avg $61.85